Colorectal cancer, lung cancer, lymphoma and more with new immunotherapy treatments, vaccines, cancer stem cell agents, cancer biomarkers and combination trials. From masses of data we list key drugs and summarise response rates in trials.

November newletter - focus on Advances in colorectal cancer